Risk Factors for Gastrointestinal Colonization by ESBL-Producing Klebsiella pneumoniae and Escherichia coli in Anaesthesiology and Reanimation Intensive Care Unit

被引:0
|
作者
Mizrakci, Serpil Oguz [1 ]
Arda, Bilgin [2 ]
Erdem, Huseyin Aytac [2 ]
Uyar, Mehmet [3 ]
Tunger, Alper [4 ]
Sipahi, Oguz Resat [2 ]
Ulusoy, Sercan [2 ]
机构
[1] Medline Antalya Private Hosp, Infect Dis & Clin Microbiol Clin, Antalya, Turkey
[2] Ege Univ, Tip Fak, Enfeksiyon Hastaliklari & Klin Mikrobiyol Anabili, TR-35100 Izmir, Turkey
[3] Ege Univ, Fac Med, Dept Anaesthesiol & Reanimat, TR-35100 Izmir, Turkey
[4] Ege Univ, Fac Med, Dept Med Microbiol, TR-35100 Izmir, Turkey
来源
MIKROBIYOLOJI BULTENI | 2013年 / 47卷 / 02期
关键词
Extended-spectrum beta-lactamase; Klebsiella pneumoniae; Escherichia coli; intensive care unit; gastrointestinal colonization; nosocomial infection; INFECTION; ACQUISITION; RESISTANCE; OUTBREAK;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In this study it was aimed to investigate the risk factors for gastrointestinal colonization by extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae and Escherichia coli in intensive care unit (ICU) of anaesthesiology and reanimation, Ege University Faculty of Medicine, Izmir, Turkey. This study was performed prospectively on adult patients hospitalized in ICU of anaesthesiology and reanimation and rectal swab cultures were performed in all patients in the first 48 hours of hospitalization and every one week until discharge or death. Samples were transported to the laboratory in Stuart transport medium and were cultured on two EMB agar plates (one including 4 mg/L ceftazidime) and incubated for 48 hours. E.coli and K.pneumoniae isolates were identified by conventional methods. Antibiotic susceptibility tests were performed by disc diffusion method on Mueller Hinton agar and interpreted according to CLSI guidelines. ESBL was confirmed by double disc synergy test. A total of 140 patients (49 female 91 male; age range: 18-83 years, mean age: 56.3 years) were evaluated, and 41(29.3%) of the patients were found to be colonized with ESBL positive E.coli (n=39) or K.pneumoniae (n=2). The mean time for colonization was 11.15 +/- 10.91 (range between 2-39) days. Age and gender of the patients and antibiotic consumption before or during the stay in ICU of anaesthesiology and reanimation were not found to be associated with colonization (p>0.05). However length of ICU of anaesthesiology and reanimation stay in colonized patients was longer than non-colonized patients (27.59 +/- 22.52 vs. 17.78 +/- 11.74 days; p<0.05). Infectious episodes developed in 22% (9/41) of the colonized cases and three of the nine strains were isolated from the blood cultures, five from the urine cultures and one from both blood and bronchoalveolar lavage cultures. ESBL-positive E.coli or K.pneumoniae colonization was found as an independent risk factor for the development of infection (9/41 vs. 4/99 cases; p=0.002). Forward logistic regression analysis revealed that diabetes mellitus, immunosuppresive drug use and length of intubation were associated with ESBL-positive E.coli or K.pneumoniae colonization (p<0.05). The results of this study indicated that the risk of development of infection was significantly high in intensive care patients colonized by ESBL positive E.coli and K.pneumoniae and the identification of the related risk factors was critically important for the establishment of effective control measures.
引用
收藏
页码:223 / 229
页数:7
相关论文
共 50 条
  • [21] High prevalence of ESBL-producing Escherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China
    Quan, Jingjing
    Zhao, Dongdong
    Liu, Lilin
    Chen, Yan
    Zhou, Jiancang
    Jiang, Yan
    Du, Xiaoxing
    Zhou, Zhihui
    Akova, Murat
    Yu, Yunsong
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (01) : 273 - 280
  • [22] Endemic extended-spectrum β-lactamase-producing Klebsiella pneumoniae at an intensive care unit:: Risk factors for colonization and infection
    Martins, IS
    Pessoa-Silva, CL
    Nouer, SA
    De Araujo, EGP
    Ferreira, ALP
    Riley, LW
    Moreira, BM
    MICROBIAL DRUG RESISTANCE, 2006, 12 (01) : 50 - 58
  • [23] Extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit:: risk factors for infection and colonization
    Pessoa-Silva, CL
    Moreira, BM
    Almeida, VC
    Flannery, B
    Lins, MCA
    Sampaio, JLM
    Teixeira, LM
    Miranda, LEV
    Riley, LW
    Gerberding, JL
    JOURNAL OF HOSPITAL INFECTION, 2003, 53 (03) : 198 - 206
  • [24] Molecular epidemiology of ESBL-producing Klebsiella pneumoniae isolates in intensive care units of a tertiary care hospital, North of Iran
    Ghaffarian, Fatemeh
    Hedayati, Mojtaba
    Ebrahim-Saraie, Hadi Sedigh
    Roushan, Zahra Atrkar
    Mojtahedi, Ali
    CELLULAR AND MOLECULAR BIOLOGY, 2018, 64 (07) : 75 - 79
  • [25] Innovative Insights into In Vitro Activity of Colloidal Platinum Nanoparticles against ESBL-Producing Strains of Escherichia coli and Klebsiella pneumoniae
    Vukoja, Damir
    Vlainic, Josipa
    Ljolic Bilic, Vanja
    Martinaga, Lela
    Rezic, Iva
    Brlek Gorski, Diana
    Kosalec, Ivan
    PHARMACEUTICS, 2022, 14 (08)
  • [26] In Vitro Activity of Cefotetan against ESBL-Producing Escherichia coli and Klebsiella pneumoniae Bloodstream Isolates from the MERINO Trial
    Stewart, Adam G.
    Cottrell, Kyra
    Henderson, Andrew
    Vemuri, Kanthi
    Bauer, Michelle J.
    Paterson, David L.
    Harris, Patrick N. A.
    MICROBIOLOGY SPECTRUM, 2021, 9 (01): : 1 - 6
  • [27] Carriage of ESBL-producing Klebsiella pneumoniae and Escherichia coli among children in rural Ghana: a cross-sectional study
    Akenten, Charity Wiafe
    Khan, Neyaz Ahmed
    Mbwana, Joyce
    Krumkamp, Ralf
    Fosu, Dennis
    Paintsil, Ellis Kobina
    Boahen, Kennedy Gyau
    Osei-Mensa, James
    Maiga-Ascofare, Oumou
    May, Juergen
    Obiri-Danso, Kwasi
    Phillips, Richard Odame
    Ofori, Linda Aurelia
    Dekker, Denise
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2023, 12 (01)
  • [28] ESBL-producing Escherichia coli and Klebsiella pneumoniae: The most prevalent clinical isolates obtained between 2005 and 2012 in Mexico
    Barrios, Humberto
    Garza-Ramos, Ulises
    Mejia-Miranda, Ilse
    Reyna-Flores, Fernando
    Sanchez-Perez, Alejandro
    Mosqueda-Garcia, Dalila
    Silva-Sanchez, Jesus
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2017, 10 : 243 - 246
  • [29] Characterization of ESBL-producing Escherichia coli and Klebsiella pneumoniae strains isolated from urine of nonhospitalized patients in the Zagreb region
    Marijan, Tatjana
    Plecko, Vanda
    Vranes, Jasmina
    Dzepina, Ana Mlinaric
    Bedenic, Branka
    Kalenic, Smilja
    MEDICINSKI GLASNIK, 2010, 7 (01) : 46 - 53
  • [30] Favourable effect of clavulanic acid on the minimum inhibitory concentrations of cefixime and ceftibuten in ESBL-producing Escherichia coli and Klebsiella pneumoniae
    Martinez-Guerra, Bernardo Alfonso
    Xancal-Salvador, Luis Fernando
    Esteban-Kenel, Veronica
    Tello-Mercado, Andrea Carolina
    Bobadilla-del-Valle, Miriam
    Sifuentes-Osornio, Jose
    Ponce-de-Leon, Alfredo
    Gonzalez-Lara, Maria Fernanda
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2024, 38 : 212 - 215